
Andrew J. Golden
Examiner (ID: 17057, Phone: (571)270-7935 , Office: P/1757 )
| Most Active Art Unit | 1726 |
| Art Unit(s) | 1757, 1725, 1726, 1755 |
| Total Applications | 703 |
| Issued Applications | 268 |
| Pending Applications | 94 |
| Abandoned Applications | 375 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20033559
[patent_doc_number] => 20250171781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => Linear DNA with Enhanced Resistance Against Exonucleases
[patent_app_type] => utility
[patent_app_number] => 19/054584
[patent_app_country] => US
[patent_app_date] => 2025-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33831
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19054584
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/054584 | Linear DNA with Enhanced Resistance Against Exonucleases | Feb 13, 2025 | Pending |
Array
(
[id] => 20033582
[patent_doc_number] => 20250171804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-29
[patent_title] => COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/934041
[patent_app_country] => US
[patent_app_date] => 2024-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18934041
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/934041 | Composition for regulating production of interfering ribonucleic acid | Oct 30, 2024 | Issued |
Array
(
[id] => 20438858
[patent_doc_number] => 12509686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-30
[patent_title] => Composition for regulating production of interfering ribonucleic acid
[patent_app_type] => utility
[patent_app_number] => 18/934005
[patent_app_country] => US
[patent_app_date] => 2024-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1764
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18934005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/934005 | Composition for regulating production of interfering ribonucleic acid | Oct 30, 2024 | Issued |
Array
(
[id] => 19528587
[patent_doc_number] => 20240352489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS
[patent_app_type] => utility
[patent_app_number] => 18/763490
[patent_app_country] => US
[patent_app_date] => 2024-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36665
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18763490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/763490 | METHODS AND COMPOSITIONS FOR MODIFYING A TARGETED LOCUS | Jul 2, 2024 | Pending |
Array
(
[id] => 20227392
[patent_doc_number] => 12416035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Recombinant particle protein product suitable for industrial production and preparation method therefor
[patent_app_type] => utility
[patent_app_number] => 18/743724
[patent_app_country] => US
[patent_app_date] => 2024-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 5828
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18743724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/743724 | Recombinant particle protein product suitable for industrial production and preparation method therefor | Jun 13, 2024 | Issued |
Array
(
[id] => 19418793
[patent_doc_number] => 20240294916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/653253
[patent_app_country] => US
[patent_app_date] => 2024-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 68664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653253
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/653253 | SMALL INTERFERING RNA TARGETING CFB AND USES THEREOF | May 1, 2024 | Pending |
Array
(
[id] => 20165266
[patent_doc_number] => 20250257312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => CONTAMINATION CONTROL WHEN GROWING GREEN ALGAE
[patent_app_type] => utility
[patent_app_number] => 18/640396
[patent_app_country] => US
[patent_app_date] => 2024-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18640396
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/640396 | CONTAMINATION CONTROL WHEN GROWING GREEN ALGAE | Apr 18, 2024 | Pending |
Array
(
[id] => 19528556
[patent_doc_number] => 20240352458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => DOUBLE STRANDED NUCLEIC ACID COMPOUNDS INHIBITING ZPI
[patent_app_type] => utility
[patent_app_number] => 18/624912
[patent_app_country] => US
[patent_app_date] => 2024-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48527
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 353
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18624912
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/624912 | DOUBLE STRANDED NUCLEIC ACID COMPOUNDS INHIBITING ZPI | Apr 1, 2024 | Pending |
Array
(
[id] => 19381288
[patent_doc_number] => 20240271158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => Circular RNA For Translation In Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 18/607256
[patent_app_country] => US
[patent_app_date] => 2024-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26749
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18607256
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/607256 | Circular RNA For Translation In Eukaryotic Cells | Mar 14, 2024 | Pending |
Array
(
[id] => 20129401
[patent_doc_number] => 12371705
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Inducible promoter for rice expression system, synthetic biological platform and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/604547
[patent_app_country] => US
[patent_app_date] => 2024-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 0
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18604547
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/604547 | Inducible promoter for rice expression system, synthetic biological platform and use thereof | Mar 13, 2024 | Issued |
Array
(
[id] => 19172877
[patent_doc_number] => 20240158851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD FOR DIAGNOSING DRUG ADDICTION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR DRUG ADDICTION AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DRUG ADDICTION
[patent_app_type] => utility
[patent_app_number] => 18/420013
[patent_app_country] => US
[patent_app_date] => 2024-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420013
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/420013 | METHOD FOR DIAGNOSING DRUG ADDICTION, METHOD FOR SCREENING THERAPEUTIC AGENT FOR DRUG ADDICTION AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DRUG ADDICTION | Jan 22, 2024 | Pending |
Array
(
[id] => 19768521
[patent_doc_number] => 20250049947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => PAPN MUTANT, METHOD FOR SITE-DIRECTED MODIFICATION OF PAPN GENE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/409684
[patent_app_country] => US
[patent_app_date] => 2024-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8035
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18409684
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/409684 | PAPN MUTANT, METHOD FOR SITE-DIRECTED MODIFICATION OF PAPN GENE AND USE THEREOF | Jan 9, 2024 | Pending |
Array
(
[id] => 19172833
[patent_doc_number] => 20240158807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => Circular RNA For Translation In Eukaryotic Cells
[patent_app_type] => utility
[patent_app_number] => 18/544160
[patent_app_country] => US
[patent_app_date] => 2023-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18544160
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/544160 | Circular RNA for translation in eukaryotic cells | Dec 17, 2023 | Issued |
Array
(
[id] => 19800789
[patent_doc_number] => 20250066714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => CONTAMINATION CONTROL WHEN GROWING YEASTS
[patent_app_type] => utility
[patent_app_number] => 18/532043
[patent_app_country] => US
[patent_app_date] => 2023-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18532043
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/532043 | Contamination control when growing yeasts | Dec 6, 2023 | Issued |
Array
(
[id] => 19326164
[patent_doc_number] => 12043830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editing
[patent_app_type] => utility
[patent_app_number] => 18/512068
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 4155
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18512068
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/512068 | Application of prokaryotic Argonaute protein with only RNA target cleavage activity in RNA editing | Nov 16, 2023 | Issued |
Array
(
[id] => 20302643
[patent_doc_number] => 12448622
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Oligonucleotides
[patent_app_type] => utility
[patent_app_number] => 18/213116
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 19
[patent_no_of_words] => 22967
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18213116
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/213116 | Oligonucleotides | Jun 21, 2023 | Issued |
Array
(
[id] => 18726206
[patent_doc_number] => 20230340469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-26
[patent_title] => TRANS-SPLICING SYSTEM FOR TISSUE-SPECIFIC REPLACEMENT OF RNA SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 18/189896
[patent_app_country] => US
[patent_app_date] => 2023-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18189896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/189896 | TRANS-SPLICING SYSTEM FOR TISSUE-SPECIFIC REPLACEMENT OF RNA SEQUENCES | Mar 23, 2023 | Pending |
Array
(
[id] => 18692990
[patent_doc_number] => 20230323358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCER
[patent_app_type] => utility
[patent_app_number] => 18/179573
[patent_app_country] => US
[patent_app_date] => 2023-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179573
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179573 | COMPOSITION AND USE OF siRNAs AGAINST VEGFR2 AND TGF-BETA1 IN COMBINATION THERAPY FOR CANCER | Mar 6, 2023 | Pending |
Array
(
[id] => 18707552
[patent_doc_number] => 20230330128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES
[patent_app_type] => utility
[patent_app_number] => 18/179064
[patent_app_country] => US
[patent_app_date] => 2023-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39120
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18179064
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/179064 | OLIGOMERS HAVING BICYCLIC SCAFFOLD MOIETIES | Mar 5, 2023 | Pending |
Array
(
[id] => 19203119
[patent_doc_number] => 20240175018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/178470
[patent_app_country] => US
[patent_app_date] => 2023-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 172739
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18178470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/178470 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF | Mar 2, 2023 | Pending |